Skip Navigation


Human Molecular Genetics Advance Access originally published online on April 29, 2008
Human Molecular Genetics 2008 17(15):2390-2404; doi:10.1093/hmg/ddn139
This Article
Right arrow Full Text Freely available
Right arrow FREE Full Text (PDF) Freely available
Right arrow Supplementary Data
Right arrow All Versions of this Article:
17/15/2390    most recent
ddn139v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrowRequest Permissions
Google Scholar
Right arrow Articles by Warby, S. C.
Right arrow Articles by Hayden, M. R.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Warby, S. C.
Right arrow Articles by Hayden, M. R.
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

© The Author 2008. Published by Oxford University Press. All rights reserved. For Permissions, please email: journals.permissions@oxfordjournals.org

Activated caspase-6 and caspase-6-cleaved fragments of huntingtin specifically colocalize in the nucleus

Simon C. Warby1, Crystal N. Doty1, Rona K. Graham1, Jeffrey B. Carroll1, Yu-Zhou Yang1, Roshni R. Singaraja1, Christopher M. Overall2 and Michael R. Hayden1,*

1 Centre for Molecular Medicine and Therapeutics (CMMT), University of British Columbia, 980 West 28th Avenue, Vancouver, British Columbia, Canada V5Z 4H4 2 Department of Oral, Biological and Medical Sciences and Biochemistry and Molecular Biology, Centre for Blood Research, University of British Columbia, Canada V6T 1Z3

* To whom correspondence should be addressed at: Centre For Molecular Medicine and Therapeutics, Children and Family Research Institute, 980 West 28th Avenue, Vancouver, British Columbia V5Z 4H4. Tel: +1 6048753535; Fax: +1 6048753819; Email: mrh{at}cmmt.ubc.ca

Received January 15, 2008; Revised April 21, 2008; Accepted April 28, 2008

Proteolysis of mutant huntingtin is crucial to the development of Huntington disease (HD). Specifically preventing proteolysis at the capase-6 (C6) consensus sequence at amino acid 586 of mutant huntingtin prevents the development of behavioural, motor and neuropathological features in a mouse model of HD. However, the mechanism underlying the selective toxicity of the 586 amino acid cleavage event is currently unknown. We have examined the subcellular localization of different caspase proteolytic fragments of huntingtin using neo-epitope antibodies. Our data suggest that the nucleus is the primary site of htt cleavage at amino acid 586. Endogenously cleaved 586 amino acid fragments are enriched in the nucleus of immortalized striatal cells and primary striatal neurons where they co-localize with active C6. Cell stress induced by staurosporine results in the nuclear translocation and activation of C6 and an increase in 586 amino acid fragments of huntingtin in the nucleus. In comparison, endogenous caspase-2/3-generated huntingtin 552 amino acid fragments localize to the perinuclear region. The different cellular itineraries of endogenously generated caspase products of huntingtin may provide an explanation for the selective toxicity of huntingtin fragments cleaved at amino acid 586.


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
J. Biol. Chem.Home page
T. Ratovitski, M. Gucek, H. Jiang, E. Chighladze, E. Waldron, J. D'Ambola, Z. Hou, Y. Liang, M. A. Poirier, R. R. Hirschhorn, et al.
Mutant Huntingtin N-terminal Fragments of Specific Size Mediate Aggregation and Toxicity in Neuronal Cells
J. Biol. Chem., April 17, 2009; 284(16): 10855 - 10867.
[Abstract] [Full Text] [PDF]


Home page
BrainHome page
M. A. Pouladi, R. K. Graham, J. M. Karasinska, Y. Xie, R. D. Santos, A. Petersen, and M. R. Hayden
Prevention of depressive behaviour in the YAC128 mouse model of Huntington disease by mutation at residue 586 of huntingtin
Brain, April 1, 2009; 132(4): 919 - 932.
[Abstract] [Full Text] [PDF]


Home page
DMMHome page
D. E. Ehrnhoefer, S. L. Butland, M. A. Pouladi, and M. R. Hayden
Mouse models of Huntington disease: variations on a theme
Dis. Model. Mech., March 1, 2009; 2(3-4): 123 - 129.
[Abstract] [Full Text] [PDF]


Home page
J. Neurosci.Home page
J. E. Young, G. A. Garden, R. A. Martinez, F. Tanaka, C. Miguel Sandoval, A. C. Smith, B. L. Sopher, A. Lin, K. H. Fischbeck, L. M. Ellerby, et al.
Polyglutamine-Expanded Androgen Receptor Truncation Fragments Activate a Bax-Dependent Apoptotic Cascade Mediated by DP5/Hrk
J. Neurosci., February 18, 2009; 29(7): 1987 - 1997.
[Abstract] [Full Text] [PDF]



Disclaimer: Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.